申请人:The Board of Regents of the University of Oklahoma
公开号:US11447452B2
公开(公告)日:2022-09-20
Benzyl derivative compounds having peroxisome proliferator-activated receptor α (PPARα) agonistic activity, compositions containing such compounds, and methods of their use in enhancing PPARα activity for treating diseases and/or conditions involving inflammation and/or angiogenesis, particularly ocular diseases and/or conditions such as but not limited to retinal inflammation, retinal neovascularization, retinal vascular leakage, retinopathy of prematurity, diabetic retinopathy, age-related macular degeneration, and diabetic macular edema are disclosed.
本发明公开了具有过氧化物酶体增殖激活受体α(PPARα)激动活性的苄基衍生物化合物、含有此类化合物的组合物,以及将其用于增强 PPARα 活性以治疗涉及炎症和/或血管生成的疾病和/或病症的方法,特别是眼部疾病和/或病症,如但不限于视网膜炎症、视网膜新生血管、视网膜血管渗漏、早产儿视网膜病变、糖尿病视网膜病变、老年性黄斑变性和糖尿病黄斑水肿。